February 11, 2025 · Form 4 insider transaction
Biller Jonathan sold 3,433 shares of Vertex Pharmaceuticals Incorporated at $459.87 per share, a transaction worth $1.58M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Transaction made pursuant to Mr. Biller's company approved trading plan under Rule 10b5-1, which was entered into on 02/13/2024.; Mr. Biller undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.; Open market sales reported on this line occurred at a weighted average price of $459.87 (range $459.83 to $460.00).